Healthcare Triangle
HCTI
1 hedge funds and large institutions have $1.22M invested in Healthcare Triangle in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
2,399% more capital inflows, than outflows
Capital inflows: $1.92M | Capital outflows: $77K
7.9% more ownership
Funds ownership: 0.45% → 8.35% (+7.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
+$1.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$30K |
| 2 |
Jane Street
New York
|
-$20K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14K |
| 4 |
Two Sigma Securities
New York
|
-$11K |
| 5 |
Morgan Stanley
New York
|
-$2K |
HCTI Hedge Fund Activity: Q3 2022 in Review
1 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Healthcare Triangle (HCTI) for Q3 2022, worth a combined $1.22M — up 660% from $161K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new HCTI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.92M. The largest seller was Citadel Advisors, cutting an estimated $30K.
- 1 institutional investor held Healthcare Triangle (HCTI) as of Q3 2022, up from 0 in Q2 2022.
- Funds reported $1.22M of Healthcare Triangle stock for Q3 2022, up 660% quarter-over-quarter.
- 1 fund opened new Healthcare Triangle positions in Q3 2022 and 0 closed out, a net change of +1 holder.
- The largest Healthcare Triangle buyer in Q3 2022 was Armistice Capital, an estimated $1.92M added.
- The largest Healthcare Triangle seller in Q3 2022 was Citadel Advisors, an estimated $30K sold.
Based on aggregated 13F filings for Q3 2022.